MIRA INFORM REPORT

 

 

Report Date :

06.07.2013

 

IDENTIFICATION DETAILS

 

Name :

JIANGSU LANFENG BIO CHEMICAL CO LTD

 

 

Registered Office :

No. Suhua Road Xinyi Economic Development Zone Xuzhou, 221400

 

 

Country :

China

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

24.09.2007

 

 

Legal Form :

Public Independent

 

 

Line of Business :

Manufacture of pesticides and other agro-chemical products

 

 

No. of Employees :

1,629

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

China

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

CHINA - ECONOMIC OVERVIEW

 

Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, creation of a diversified banking system, development of stock markets, rapid growth of the private sector, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors it considers important to "economic security," explicitly looking to foster globally competitive national champions. After keeping its currency tightly linked to the US dollar for years, in July 2005 China revalued its currency by 2.1% against the US dollar and moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2012 stood as the second-largest economy in the world after the US, having surpassed Japan in 2001. The dollar values of China's agricultural and industrial output each exceed those of the US; China is second to the US in the value of services it produces. Still, per capita income is below the world average. The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic demand; (b) sustaining adequate job growth for tens of millions of migrants and new entrants to the work force; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2011 more than 250 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development. In 2010-11, China faced high inflation resulting largely from its credit-fueled stimulus program. Some tightening measures appear to have controlled inflation, but GDP growth consequently slowed to under 8% for 2012. An economic slowdown in Europe contributed to China's, and is expected to further drag Chinese growth in 2013. Debt overhang from the stimulus program, particularly among local governments, and a property price bubble challenge policy makers currently. The government's 12th Five-Year Plan, adopted in March 2011, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent on exports in the future. However, China has made only marginal progress toward these rebalancing goals

Source : CIA


Company name and address

 

Jiangsu Lanfeng Bio Chemical Co Ltd

                                                                                                                                                    

 

No. Suhua Road

Xinyi Economic Development Zone

 

Xuzhou, 221400

China

 

 

Tel:

86-516-88920479

Fax:

86-516-88923712

 

www.jslanfeng.com

 

Employees:

1,629

Company Type:

Public Independent

Traded:

Shenzhen Stock Exchange:

002513

Incorporation Date:

24-Sep-2007

Auditor:

Jiangsu Gongzheng Tianye CPA

Financials in:

 USD (mil)

Fiscal Year End:

31-Dec-2012

Reporting Currency:

Chinese Renminbi

Annual Sales:

201.0  1

Net Income:

9.4

Total Assets:

373.9  2

Market Value:

316.3

 

(21-Jun-2013)

                                       

Business Description        

 

Jiangsu Lanfeng Bio-chemical Co., Ltd. is principally engaged in the production and distribution of raw materials and preparations of fungicides, insecticides and herbicides, as well as the fine chemical intermediate products. The primarily provides carbendazim, thiophanate methyl, benomyl, hexazinone, metazachlor, spermine, methyl chloroformate and ethyl chloroformate, among others. The Company distributes its products in domestic market and to overseas markets. For the fiscal year ended 31 December 2012, Jiangsu Lanfeng Bio Chemical Co Ltd revenues increased 11% to RMB1.27B. Net income decreased 29% to RMB59.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Interest Inocme decrease of 94% to RMB704K (income), Non-operating income decrease of 81% to RMB2.2M (income).

          

Industry                                                                                                                                     

 

Industry

Chemical Manufacturing

ANZSIC 2006:

1832 - Pesticide Manufacturing

NACE 2002:

2420 - Manufacture of pesticides and other agro-chemical products

NAICS 2002:

32532 - Pesticide and Other Agricultural Chemical Manufacturing

UK SIC 2003:

2420 - Manufacture of pesticides and other agro-chemical products

UK SIC 2007:

2020 - Manufacture of pesticides and other agrochemical products

US SIC 1987:

2879 - Pesticides and Agricultural Chemicals, Not Elsewhere Classified

                        

Key Executives

   

 

Name

Title

Kang Chen

Secretary of the Board, Deputy General Manager

Siyu Gu

Deputy General Manager

Jun Xiong

Chief Financial Officer

Zhenhua Yang

Chairman of the Board

Bin Geng

Director

 

Significant Developments                                                                          

 

Topic

#*

Most Recent Headline

Date

Negative Earnings Pre-Announcement

2

Jiangsu Lanfeng Bio-chemical CoLtd Revises FY 2012 Q1 to Q3 Net Profit Outlook

10-Oct-2012

Other Earnings Pre-Announcement

1

Jiangsu Lanfeng Bio-chemical CoLtd Announces FY 2012 Net Profit Outlook

25-Oct-2012

Debt Financing / Related

1

Jiangsu Lanfeng Bio-chemical CoLtd to Guarantee Bank Loan for Subsidiary

27-Nov-2012

Special Events / Other

3

Jiangsu Lanfeng Bio-chemical CoLtd's Subsidiary Receives Subsidy

9-Apr-2013

Dividends

2

Jiangsu Lanfeng Bio-chemical CoLtd Announces FY 2012 Dividend Payment Date

3-Jun-2013

      

Financial Summary                                                                                                                        

 

As of 31-Dec-2012

Key Ratios

Company

Industry

Current Ratio (MRQ)

0.76

2.18

Quick Ratio (MRQ)

0.52

1.35

Debt to Equity (MRQ)

0.75

0.82

Sales 5 Year Growth

18.17

6.26

Net Profit Margin (TTM) %

4.67

10.56

Return on Assets (TTM) %

2.90

8.26

Return on Equity (TTM) %

5.10

22.07

 

 

 

   Stock Snapshot                                  

 

Traded: Shenzhen Stock Exchange: 002513

 

As of 21-Jun-2013

   Financials in: CNY

Recent Price

9.10

 

EPS

0.28

52 Week High

15.38

 

Price/Sales

1.53

52 Week Low

8.07

 

Dividend Rate

0.10

Avg. Volume (mil)

1.44

 

Price/Earnings

35.60

Market Value (mil)

1,939.39

 

Price/Book

1.64

 

Price % Change

Rel S&P 500%

4 Week

-13.66%

-1.26%

13 Week

-18.02%

-5.86%

52 Week

-17.27%

-1.55%

Year to Date

-8.82%

2.16%

 

 

1 - Profit & Loss Item Exchange Rate: USD 1 = CNY 6.310555
2 - Balance Sheet Item Exchange Rate: USD 1 = CNY 6.2357

 

 

Corporate Overview

 

Location
No. Suhua Road
Xinyi Economic Development Zone
Xuzhou, 221400
China

 

Tel:

86-516-88920479

Fax:

86-516-88923712

 

www.jslanfeng.com

Quote Symbol - Exchange

002513 - Shenzhen Stock Exchange

Sales CNY(mil):

1,268.6

Assets CNY(mil):

2,331.5

Employees:

1,629

Fiscal Year End:

31-Dec-2012

 

Industry:

Chemical Manufacturing

Incorporation Date:

24-Sep-2007

Company Type:

Public Independent

Quoted Status:

Quoted

 

Secretary of the Board, Deputy General Manager:

Kang Chen

 

Industry Codes

 

ANZSIC 2006 Codes:

1832

-

Pesticide Manufacturing

1812

-

Basic Organic Chemical Manufacturing

 

NACE 2002 Codes:

2420

-

Manufacture of pesticides and other agro-chemical products

2414

-

Manufacture of other organic basic chemicals

 

NAICS 2002 Codes:

32532

-

Pesticide and Other Agricultural Chemical Manufacturing

325199

-

All Other Basic Organic Chemical Manufacturing

 

US SIC 1987:

2879

-

Pesticides and Agricultural Chemicals, Not Elsewhere Classified

2869

-

Industrial Organic Chemicals, Not Elsewhere Classified

 

UK SIC 2003:

2420

-

Manufacture of pesticides and other agro-chemical products

2414

-

Manufacture of other organic basic chemicals

 

UK SIC 2007:

2020

-

Manufacture of pesticides and other agrochemical products

2014

-

Manufacture of other organic basic chemicals

 

Business Description

Jiangsu Lanfeng Bio-chemical Co., Ltd. is principally engaged in the production and distribution of raw materials and preparations of fungicides, insecticides and herbicides, as well as the fine chemical intermediate products. The primarily provides carbendazim, thiophanate methyl, benomyl, hexazinone, metazachlor, spermine, methyl chloroformate and ethyl chloroformate, among others. The Company distributes its products in domestic market and to overseas markets. For the fiscal year ended 31 December 2012, Jiangsu Lanfeng Bio Chemical Co Ltd revenues increased 11% to RMB1.27B. Net income decreased 29% to RMB59.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Interest Inocme decrease of 94% to RMB704K (income), Non-operating income decrease of 81% to RMB2.2M (income).

 

More Business Descriptions

Jiangsu Lanfeng Biochemical Co., Ltd. (JLBC) is an agrochemical company, based in China. The company provides research, development, manufacture and distribution of agricultural chemical products. Its products include fungicides, insecticides, herbicides and intermediates related to phosgene. The company offers products such as propamcarb, imidacloprid, pyridaben, acephate, thiophanate, carbendazim, mesotrione, dicamba, glyphosate, monolinuron, tebuthiuron, metamitron, isoproturon, diuron, metazachlor, and hexazinone. It also operates in Southeast Asia, North Korea, Europe, Brazil, the US, South Africa and India. The company markets its products in domestic and international markets. JLBC is headquartered in Jiangsu, China.The company reported revenues of (Renminbi) CNY 1,268.55 million during the fiscal year ended December 2012, an increase of 10.96% over 2011. The operating profit of the company was CNY 69.37 million during the fiscal year 2012, a decrease of 29.88% from 2011. The net profit of the company was CNY 59.23 million during the fiscal year 2012, a decrease of 29.03% from 2011.

 

 

 

 

 

 

Financial Data

Financials in:

CNY(mil)

 

Revenue:

1,268.6

Net Income:

59.2

Assets:

2,331.5

Long Term Debt:

0.0

 

Total Liabilities:

1,149.9

 

Working Capital:

0.3

 

 

 

Date of Financial Data:

31-Dec-2012

 

1 Year Growth

11.0%

-29.0%

33.1%

 

Key Corporate Relationships

Auditor:

Jiangsu Gongzheng Tianye CPA

 

Auditor:

Jiangsu Gongzheng Tianye CPA

 

 

 

 

 

 

 

 

 

Competitors Report



CompanyName

Location

Employees

Ownership

China Shenghua Group Agrochemical Company

Shanghai, China

 

Private

Jiangsu Huifeng Agrochemical Co

Yancheng, China

1,811

Public

Jiangsu Yangnong Chemical Co.,Ltd.

Yangzhou, China

1,160

Public

 

 

 

Executives Report

 

Board of Directors

 

Name

Title

Function

Zhenhua Yang

 

Chairman of the Board

Chairman

Biography:

Mr. Yang Zhenhua has been Chairman of the Board in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He is Chairman of the Board, Vice Chairman of the Board, General Manager and Director in other 15 companies. He used to be Head of Factory in a Suzhou-based chemical industry factory, as well as Chairman of the Board and General Manager in a Suzhou-based pesticide group company.

 

Age: 64

 

Huazhong Liang

 

Vice Chairman of the Board, General Manager

Vice-Chairman

 

 

Biography:

Mr. Liang Huazhong has been Vice Chairman of the Board and General Manager in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He is also serving as Chairman of the Board in an investment company. He used to be Chairman of the Board and General Manager in other two companies.

 

Age: 57

 

Bin Geng

 

Director

Director/Board Member

 

 

Biography:

Mr. Geng Bin has been Director in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He is also Deputy General Manager, Director, Chairman of the Board and General Manager in other six companies. He used to be Deputy Chief Engineer and Head-Development in a Jiangsu-based pesticide group.

 

Age: 48

 

Ziqiang Gu

 

Director

Director/Board Member

 

 

Biography:

Mr. Gu Ziqiang has been Director in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He is also serving as Director in other six companies.

 

Age: 57

 

Rengen Hua

 

Independent Director

Director/Board Member

 

 

Age: 62

 

Qiuping Lu

 

Independent Director

Director/Board Member

 

 

Biography:

Ms. Lu Qiuping has been Independent Director in Jiangsu Lanfeng Bio-chemical Co., Ltd. since April 13, 2008. She is Certified Public Accountant.

 

Age: 54

 

Shubao Sun

 

Independent Director

Director/Board Member

 

 

Biography:

Mr. Sun Shubao has been serving as Independent Director in Jiangsu Lanfeng Bio Chemical Co., Ltd. since April 13, 2008. He is also serving as Independent Director in other two companies.

 

Age: 50

 

Yi Wang

 

Independent Director

Director/Board Member

 

 

Biography:

Mr. Wang Yi has been Independent Director in Jiangsu Lanfeng Bio-chemical Co., Ltd. since April 13, 2008. He is also Chairman of the Board in a Shanghai-based investment management company. He used to be Vice President in another company. He holds a Ph.D. in Economics. He is Guest Professor in Asia School of Business, Singapore.

 

Age: 44

 

Jun Xiong

 

Chief Financial Officer

Director/Board Member

 

 

Biography:

Mr. Xiong Jun has been Chief Financial Officer in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He was Secretary of the Board in the Company. He used to be Chief Financial Officer in another company.

 

Age: 44

 

Xizhi Xu

 

Deputy General Manager, Director

Director/Board Member

 

 

Biography:

Mr. Xu Xizhi has been Deputy General Manager and Director in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He was Chief Engineer in the Company. He is also serving as Director in an investment company.

 

Age: 47

 

Shanlong Zheng

 

Deputy General Manager, Director

Director/Board Member

 

 

Biography:

Mr. Zheng Shanlong has been Deputy General Manager and Director in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He is also serving as Director in an investment company. He used to be Assistant General Manager and Deputy General Manager in another company. He holds a Bachelor's degree.

 

Age: 48

 

 

Executives

 

Name

Title

Function

Kang Chen

 

Secretary of the Board, Deputy General Manager

Division Head Executive

Biography:

Mr. Chen Kang has been Secretary of the Board and Deputy General Manager in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He holds a Bachelor's degree.

 

Age: 48

 

Siyu Gu

 

Deputy General Manager

Division Head Executive

 

 

Biography:

Mr. Gu Siyu has been Deputy General Manager in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He was Deputy General Manager in two other companies.

 

Age: 51

 

Huazhong Liang

 

Vice Chairman of the Board, General Manager

Division Head Executive

 

 

Biography:

Mr. Liang Huazhong has been Vice Chairman of the Board and General Manager in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He is also serving as Chairman of the Board in an investment company. He used to be Chairman of the Board and General Manager in other two companies.

 

Age: 57

 

Yongsheng Shen

 

Deputy General Manager

Division Head Executive

 

 

Biography:

Mr. Shen Yongsheng has been Deputy General Manager in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He was Deputy General Manager in an agricultural chemical company.

 

Age: 50

 

Xizhi Xu

 

Deputy General Manager, Director

Division Head Executive

 

 

Biography:

Mr. Xu Xizhi has been Deputy General Manager and Director in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He was Chief Engineer in the Company. He is also serving as Director in an investment company.

 

Age: 47

 

Gang Zheng

 

Deputy General Manager

Division Head Executive

 

 

Biography:

Mr. Zheng Gang is Deputy General Manager in Jiangsu Lanfeng Bio-chemical Co., Ltd. He was Workshop Supervisor and Assistant General Manager in the Company. He used to be Workshop Supervisor in another company.

 

Age: 41

 

Shanlong Zheng

 

Deputy General Manager, Director

Division Head Executive

 

 

Biography:

Mr. Zheng Shanlong has been Deputy General Manager and Director in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He is also serving as Director in an investment company. He used to be Assistant General Manager and Deputy General Manager in another company. He holds a Bachelor's degree.

 

Age: 48

 

Jun Xiong

 

Chief Financial Officer

Finance Executive

 

 

Biography:

Mr. Xiong Jun has been Chief Financial Officer in Jiangsu Lanfeng Bio-chemical Co., Ltd. since August 25, 2007. He was Secretary of the Board in the Company. He used to be Chief Financial Officer in another company.

 

Age: 44

 

 

Significant Developments

 

 

 

Jiangsu Lanfeng Bio-chemical CoLtd Announces FY 2012 Dividend Payment Date

Jun 03, 2013


Jiangsu Lanfeng Bio-chemical CoLtd announced that it will use undistributed profits to pay a cash dividend of RMB 1(pre-tax) per 10 shares for fiscal year 2012, to shareholders of record on June 13, 2013. The Company's shares will be traded ex-dividend on June 14, 2013 and the dividend will be paid on June 14, 2013.

Jiangsu Lanfeng Bio-chemical CoLtd's Subsidiary Receives Subsidy

Apr 09, 2013


Jiangsu Lanfeng Bio-chemical CoLtd announced that its Ningxia-based wholly owned chemical subsidiary has received a subsidy of RMB 4,028,000 as enterprise development funds.

Jiangsu Lanfeng Bio-chemical CoLtd Announces FY 2012 Dividend Payment

Mar 26, 2013


Jiangsu Lanfeng Bio Chemical Co Ltd announced that it will use undistributed profits to pay a cash dividend of RMB 1(pre-tax) per 10 shares, for the fiscal year 2012.

Jiangsu Lanfeng Bio-chemical CoLtd to Guarantee Bank Loan for Subsidiary

Nov 27, 2012


Jiangsu Lanfeng Bio-chemical CoLtd announced that it will guarantee a loan of up to RMB 200 million for its wholly owned subsidiary, a Ningxia-based chemical industry company.

Jiangsu Lanfeng Bio-chemical CoLtd Announces FY 2012 Net Profit Outlook

Oct 25, 2012


Jiangsu Lanfeng Bio-chemical CoLtd announced that it expects its net profit for fiscal year (FY) 2012 to be approximately RMB 41.7324 million to RMB 83.4648 million, or to decrease by 50% to 0%, compared to that of FY 2011 (RMB 83,464,845.86). The Company cited product price decreasing rate exceeded material price decreasing rate as the main reason for this forecast.

Jiangsu Lanfeng Bio-chemical CoLtd Receives Subsidy

Oct 10, 2012


Jiangsu Lanfeng Bio-chemical CoLtd announced that it has received a subsidy of RMB 5 million as special funds.

Jiangsu Lanfeng Bio-chemical CoLtd Revises FY 2012 Q1 to Q3 Net Profit Outlook

Oct 10, 2012


Jiangsu Lanfeng Bio-chemical CoLtd announced that it expects its net profit of Q1 to Q3 for fiscal year (FY) 2012 to be RMB 38.5109 million to RMB 77.0217 million, or to decrease by 0% to 50%, compared to that of FY 2011 (RMB 77.0217 million). The Company previously announced that it expected the profit to decrease by 5% to 35%. The Company cited the decreased sales income as the main reason for the revision.

Jiangsu Lanfeng Bio-chemical CoLtd Receives Subsidy

Sep 26, 2012


Jiangsu Lanfeng Bio-chemical CoLtd announced that it has received a subsidy of RMB 10.33 million as special funds.

Jiangsu Lanfeng Bio-chemical CoLtd Revises FY 2012 H1 Net Profit Outlook

Jul 14, 2012


Jiangsu Lanfeng Bio-chemical CoLtd announced that it expects its net profit for the first half of fiscal year (FY) 2012 to be RMB 30.0929 million to RMB 46.5072 million, or to decrease 15% to 45%, compared to that of FY 2011 (RMB 54.7144 million). The Company previously announced that it expected the profit to increase -20% to 10%. The Company cited the decreased business income as the main reason for the revision.

 

Annual Income Statement

 

Financials in: USD (mil)

 

Except for share items (millions) and per share items (actual units)

 

 

 

 

  Financial Glossary

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate (Period Average)

6.310555

6.46438

6.768989

6.831007

6.950445

Auditor

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Net Sales

198.3

176.9

135.0

91.9

130.7

Revenue

198.3

176.9

135.0

91.9

130.7

    Other Revenue

2.7

-

-

-

-

Other Revenue, Total

2.7

-

-

-

-

Total Revenue

201.0

176.9

135.0

91.9

130.7

 

 

 

 

 

 

    Cost of Revenue

159.9

139.1

105.2

68.0

103.1

Cost of Revenue, Total

159.9

139.1

105.2

68.0

103.1

Gross Profit

38.3

37.8

29.9

23.9

27.5

 

 

 

 

 

 

    Selling/General/Administrative Expense

14.5

18.6

14.4

8.9

9.9

    Labor & Related Expense

3.4

-

-

-

-

    Advertising Expense

0.2

-

-

-

-

Total Selling/General/Administrative Expenses

18.2

18.6

14.4

8.9

9.9

Research & Development

4.8

-

-

-

-

    Depreciation

1.0

-

-

-

-

    Amortization of Intangibles

0.2

-

-

-

-

Depreciation/Amortization

1.1

-

-

-

-

        Interest Expense - Operating

4.7

3.7

1.5

1.9

1.9

        Interest Capitalized - Operating

-

-

-

-0.3

0.0

    Interest Expense - Net Operating

4.7

3.7

1.5

1.6

1.9

        Interest Income - Operating

-0.1

-1.9

-0.1

-0.1

-0.1

        Investment Income - Operating

0.6

1.0

0.3

0.0

0.0

    Interest/Investment Income - Operating

0.5

-0.9

0.2

-0.1

-0.1

    Interest Expense (Income) - Net Operating

0.6

-

-

-

-

Interest Expense (Income) - Net Operating Total

5.8

2.8

1.7

1.5

1.8

    Impairment-Assets Held for Use

-

0.8

0.1

-0.5

0.7

Unusual Expense (Income)

-

0.8

0.1

-0.5

0.7

    Other Operating Expense

0.2

0.3

0.6

0.3

0.2

Other Operating Expenses, Total

0.2

0.3

0.6

0.3

0.2

Total Operating Expense

190.0

161.6

121.9

78.2

115.7

 

 

 

 

 

 

Operating Income

11.0

15.3

13.2

13.6

14.9

 

 

 

 

 

 

Gain (Loss) on Sale of Assets

0.0

-0.1

0.0

-0.1

-0.1

    Other Non-Operating Income (Expense)

-0.1

-0.1

0.3

3.5

2.1

Other, Net

-0.1

-0.1

0.3

3.5

2.1

Income Before Tax

10.9

15.1

13.4

17.1

16.9

 

 

 

 

 

 

Total Income Tax

1.5

2.2

2.0

2.6

2.8

Income After Tax

9.4

12.9

11.3

14.5

14.1

 

 

 

 

 

 

Net Income Before Extraord Items

9.4

12.9

11.3

14.5

14.1

Net Income

9.4

12.9

11.3

14.5

14.1

 

 

 

 

 

 

Income Available to Common Excl Extraord Items

9.4

12.9

11.3

14.5

14.1

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

9.4

12.9

11.3

14.5

14.1

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

211.5

213.1

162.7

158.4

158.4

Basic EPS Excl Extraord Items

0.04

0.06

0.07

0.09

0.09

Basic/Primary EPS Incl Extraord Items

0.04

0.06

0.07

0.09

0.09

Diluted Net Income

9.4

12.9

11.3

14.5

14.1

Diluted Weighted Average Shares

211.5

213.1

162.7

158.4

158.4

Diluted EPS Excl Extraord Items

0.04

0.06

0.07

0.09

0.09

Diluted EPS Incl Extraord Items

0.04

0.06

0.07

0.09

0.09

Dividends per Share - Common Stock Primary Issue

0.00

0.04

0.00

0.00

0.00

Gross Dividends - Common Stock

0.0

7.6

0.0

0.0

0.0

Interest Expense, Supplemental

4.7

3.7

1.5

1.6

1.9

Interest Capitalized, Supplemental

-

-0.3

-1.5

-0.3

0.0

Depreciation, Supplemental

1.0

7.5

5.2

3.5

3.3

Total Special Items

0.2

0.8

0.1

-0.4

0.9

Normalized Income Before Tax

11.0

15.9

13.5

16.7

17.8

 

 

 

 

 

 

Effect of Special Items on Income Taxes

0.0

0.1

0.0

-0.1

0.1

Inc Tax Ex Impact of Sp Items

1.5

2.3

2.1

2.5

3.0

Normalized Income After Tax

9.5

13.6

11.5

14.1

14.8

 

 

 

 

 

 

Normalized Inc. Avail to Com.

9.5

13.6

11.5

14.1

14.8

 

 

 

 

 

 

Basic Normalized EPS

0.05

0.06

0.07

0.09

0.09

Diluted Normalized EPS

0.05

0.06

0.07

0.09

0.09

Amort of Intangibles, Supplemental

0.2

0.1

0.1

0.2

0.1

Advertising Expense, Supplemental

0.2

0.4

0.1

0.1

0.0

Research & Development Exp, Supplemental

4.8

1.7

0.5

0.4

0.6

Normalized EBIT

16.9

18.8

14.9

14.6

17.4

Normalized EBITDA

18.0

26.4

20.2

18.3

20.9

    Current Tax - Total

1.7

2.2

2.2

2.6

2.9

Current Tax - Total

1.7

2.2

2.2

2.6

2.9

    Deferred Tax - Total

-0.2

-0.1

-0.2

0.0

0.0

Deferred Tax - Total

-0.2

-0.1

-0.2

0.0

0.0

Income Tax - Total

1.5

2.2

2.0

2.6

2.8

 

 

 

Annual Balance Sheet

Financials in: USD (mil)

 

  Financial Glossary

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate

6.2357

6.294

6.5897

6.827

6.823

Auditor

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash & Equivalents

41.1

58.4

132.2

14.5

10.5

    Short Term Investments

-

-

-

0.0

0.0

Cash and Short Term Investments

41.1

58.4

132.2

14.5

10.5

        Accounts Receivable - Trade, Gross

-

31.4

16.8

11.8

-

        Provision for Doubtful Accounts

-

-2.3

-1.5

-0.6

-

    Trade Accounts Receivable - Net

39.1

29.1

15.3

11.2

11.7

    Notes Receivable - Short Term

4.1

4.9

2.1

1.4

0.3

    Other Receivables

1.9

1.4

0.4

1.2

0.5

Total Receivables, Net

45.1

35.3

17.8

13.8

12.5

    Inventories - Finished Goods

-

3.2

1.8

1.5

1.0

    Inventories - Work In Progress

-

7.9

8.0

2.9

3.7

    Inventories - Raw Materials

-

8.1

7.1

3.3

2.6

    Inventories - Other

-

-

-

0.0

-

Total Inventory

43.8

19.3

16.9

7.8

7.2

Prepaid Expenses

9.0

10.8

6.1

2.4

1.2

Total Current Assets

139.0

123.8

172.9

38.4

31.5

 

 

 

 

 

 

        Buildings

-

22.7

24.0

25.2

-

        Machinery/Equipment

-

69.3

63.1

40.2

-

    Property/Plant/Equipment - Gross

-

92.1

87.1

65.4

-

    Accumulated Depreciation

-

-22.4

-26.3

-21.6

-

Property/Plant/Equipment - Net

222.5

147.4

74.0

50.3

30.3

Intangibles, Net

10.8

5.7

2.9

6.9

5.5

    LT Investments - Other

0.7

0.8

0.8

-

-

Long Term Investments

0.7

0.8

0.8

-

-

    Deferred Income Tax - Long Term Asset

0.8

0.6

0.5

0.3

0.4

Other Long Term Assets, Total

0.8

0.6

0.5

0.3

0.4

Total Assets

373.9

278.3

251.1

95.9

67.6

 

 

 

 

 

 

Accounts Payable

41.7

18.6

9.9

10.3

7.1

Accrued Expenses

3.2

3.3

3.4

3.4

3.2

Notes Payable/Short Term Debt

126.1

45.2

40.7

21.1

21.9

Current Portion - Long Term Debt/Capital Leases

16.4

14.3

5.4

3.7

1.5

    Dividends Payable

-

-

0.0

3.2

0.0

    Customer Advances

4.1

4.0

3.8

4.9

4.1

    Income Taxes Payable

-9.5

-3.4

-1.1

-0.6

-0.3

    Other Current Liabilities

0.0

1.4

1.5

0.1

0.2

Other Current liabilities, Total

-5.4

2.0

4.2

7.6

4.0

Total Current Liabilities

182.0

83.4

63.6

46.0

37.7

 

 

 

 

 

 

    Long Term Debt

-

13.0

23.3

14.3

3.3

Total Long Term Debt

0.0

13.0

23.3

14.3

3.3

Total Debt

142.4

72.6

69.3

39.0

26.7

 

 

 

 

 

 

    Other Long Term Liabilities

2.4

0.8

0.8

0.0

0.1

Other Liabilities, Total

2.4

0.8

0.8

0.0

0.1

Total Liabilities

184.4

97.3

87.6

60.3

41.1

 

 

 

 

 

 

    Common Stock

34.2

21.2

11.2

8.1

8.1

Common Stock

34.2

21.2

11.2

8.1

8.1

Additional Paid-In Capital

97.8

108.0

112.1

0.5

0.5

Retained Earnings (Accumulated Deficit)

57.6

52.0

40.2

27.1

18.0

Total Equity

189.5

181.1

163.5

35.6

26.5

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

373.9

278.3

251.1

95.9

67.6

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

213.1

213.1

213.1

158.4

158.4

Total Common Shares Outstanding

213.1

213.1

213.1

158.4

158.4

Treasury Shares - Common Stock Primary Issue

0.0

0.0

0.0

0.0

0.0

Employees

-

1,535

1,395

1,340

1,313

Number of Common Shareholders

-

12,911

12,317

-

-

Accumulated Intangible Amort, Suppl.

-

0.6

0.4

0.5

-

Deferred Revenue - Current

4.1

4.0

3.8

4.9

4.1

 

 

 

Annual Cash Flows

Financials in: USD (mil)

 

  Financial Glossary

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate (Period Average)

6.310555

6.46438

6.768989

6.831007

6.950445

Auditor

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

Cash Receipts

206.6

175.3

140.9

101.2

145.7

Cash Payments

-167.4

-162.7

-122.1

-76.8

-121.3

Cash Taxes Paid

3.8

2.6

1.9

-3.1

-6.0

    Other Operating Cash Flow

-33.7

-12.2

-10.3

-2.6

-4.6

Changes in Working Capital

-33.7

-12.2

-10.3

-2.6

-4.6

Cash from Operating Activities

9.3

3.0

10.4

18.7

13.9

 

 

 

 

 

 

    Purchase of Fixed Assets

-68.1

-79.7

-31.3

-23.2

-8.8

Capital Expenditures

-68.1

-79.7

-31.3

-23.2

-8.8

    Acquisition of Business

-

-

-0.3

-

-

    Sale of Fixed Assets

0.0

0.3

0.1

0.0

0.0

    Sale/Maturity of Investment

-

-

-

0.0

0.0

    Other Investing Cash Flow

2.4

1.5

8.1

0.0

0.0

Other Investing Cash Flow Items, Total

2.4

1.9

7.9

0.0

0.0

Cash from Investing Activities

-65.7

-77.8

-23.4

-23.1

-8.8

 

 

 

 

 

 

    Other Financing Cash Flow

-

-

111.7

0.0

0.0

Financing Cash Flow Items

-

-

111.7

0.0

0.0

    Cash Dividends Paid - Common

-8.9

-7.3

-6.0

-4.0

-1.9

Total Cash Dividends Paid

-8.9

-7.3

-6.0

-4.0

-1.9

    Total Debt Issued

84.1

42.5

41.9

33.3

21.1

    Total Debt Reduction

-57.8

-33.8

-24.2

-20.2

-19.8

Issuance (Retirement) of Debt, Net

26.3

8.7

17.7

13.1

1.3

Cash from Financing Activities

17.5

1.4

123.3

9.2

-0.6

 

 

 

 

 

 

Foreign Exchange Effects

-0.6

-1.0

-0.3

0.0

0.0

Net Change in Cash

-39.5

-74.4

110.0

4.8

4.6

 

 

 

 

 

 

Net Cash - Beginning Balance

55.8

128.9

13.1

8.3

3.5

Net Cash - Ending Balance

16.3

54.5

123.1

13.0

8.1

Depreciation

11.5

7.5

5.2

3.5

3.3

 

 

Annual Income Statement

 

Financials in: USD (mil)

 

Except for share items (millions) and per share items (actual units)

 

 

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate (Period Average)

6.310555

6.46438

6.768989

6.831007

6.950445

Auditor

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Other Rev from Biz Related Activ.

2.7

-

-

-

-

    Other Net Sales

198.3

-

-

-

-

    Net Sales

-

176.9

135.0

91.9

130.7

Total Revenue

201.0

176.9

135.0

91.9

130.7

 

 

 

 

 

 

    Advertising Expenses

0.2

-

-

-

-

    Depreciation in SGA

1.0

-

-

-

-

    Research & Development Expense

4.8

-

-

-

-

    Amortisation of Intangibles

0.2

-

-

-

-

    Labor & Related Expenses in SGA

0.4

-

-

-

-

    Labor & Related Expenses in SGA

0.6

-

-

-

-

    Labor & Related Expenses in SGA

2.0

-

-

-

-

    Labor & Related Expenses in SGA

0.4

-

-

-

-

    Labor & Related Expenses in SGA

0.1

-

-

-

-

    Other Business Tax and Surcharges

0.0

-

-

-

-

    Cost of Sales

159.9

139.1

105.2

67.7

102.6

    Investment Income In Affilitates

-

-

-

0.0

0.0

    Business Tax and Surcharges

-

0.0

0.0

0.3

0.5

    Property & Other Taxes

0.0

-

-

-

-

    Property & Other Taxes

0.0

-

-

-

-

    Bad Debt Written-off/Provision

0.5

-

-

-

-

    Other General & Administrative Expenses

5.8

-

-

-

-

    Other Selling Expense

8.2

-

-

-

-

    General & Administrative Expenses

-

10.0

7.5

5.2

5.5

    Selling Expense

-

8.5

6.9

3.7

4.4

    Other Financial expenses

0.6

-

-

-

-

    Interest Expense

4.7

3.7

1.5

1.9

1.9

    Interest Capitalized

-

-

-

-0.3

0.0

    Interest Inocme

-0.1

-1.9

-0.1

-0.1

-0.1

    Foreign Exchange Gain/Loss

0.6

1.0

0.3

0.0

0.0

    Other Finance Expense

-

0.3

0.5

0.3

0.2

    Commission Fees

0.2

0.1

0.1

0.0

0.0

    Impairment Loss on Assets

-

0.8

0.1

-0.5

0.7

    Gain/Loss from Change in Fair Value

-

-

-

0.0

0.0

Total Operating Expense

190.0

161.6

121.9

78.2

115.7

 

 

 

 

 

 

    Gain on Sale of Fixed Assets

-

0.0

0.0

-

-

    Other Non-operating expenses

-0.4

-

-

-

-

    Non-operating income

0.3

1.7

6.8

3.6

2.3

    Loss on Sale of Fixed Assets

0.0

-0.1

0.0

-0.1

-0.1

    Non-operating expenses

-

-1.9

-6.5

-0.1

-0.2

Net Income Before Taxes

10.9

15.1

13.4

17.1

16.9

 

 

 

 

 

 

Provision for Income Taxes

1.5

2.2

2.0

2.6

2.8

Net Income After Taxes

9.4

12.9

11.3

14.5

14.1

 

 

 

 

 

 

Net Income Before Extra. Items

9.4

12.9

11.3

14.5

14.1

Net Income

9.4

12.9

11.3

14.5

14.1

 

 

 

 

 

 

Income Available to Com Excl ExtraOrd

9.4

12.9

11.3

14.5

14.1

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

9.4

12.9

11.3

14.5

14.1

 

 

 

 

 

 

Basic Weighted Average Shares

211.5

213.1

162.7

158.4

158.4

Basic EPS Excluding ExtraOrdinary Items

0.04

0.06

0.07

0.09

0.09

Basic EPS Including ExtraOrdinary Items

0.04

0.06

0.07

0.09

0.09

Diluted Net Income

9.4

12.9

11.3

14.5

14.1

Diluted Weighted Average Shares

211.5

213.1

162.7

158.4

158.4

Diluted EPS Excluding ExtraOrd Items

0.04

0.06

0.07

0.09

0.09

Diluted EPS Including ExtraOrd Items

0.04

0.06

0.07

0.09

0.09

DPS-A Share

0.00

0.04

0.00

0.00

0.00

Gross Dividends - Common Stock

0.0

7.6

0.0

0.0

0.0

Normalized Income Before Taxes

11.0

15.9

13.5

16.7

17.8

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

1.5

2.3

2.1

2.5

3.0

Normalized Income After Taxes

9.5

13.6

11.5

14.1

14.8

 

 

 

 

 

 

Normalized Inc. Avail to Com.

9.5

13.6

11.5

14.1

14.8

 

 

 

 

 

 

Basic Normalized EPS

0.05

0.06

0.07

0.09

0.09

Diluted Normalized EPS

0.05

0.06

0.07

0.09

0.09

Interest Expense

4.7

-

-

-

-

Interest Expense, Supplemental

-

3.7

1.5

1.6

1.9

Interest Capitalized, Supplemental

-

-0.3

-1.5

-0.3

0.0

BC - Depreciation of Fixed Assets

1.0

-

-

-

-

Depreciation, Supplemental

-

7.5

5.2

3.5

3.3

BC - Depreciation of Intangible Assets

0.2

-

-

-

-

Amort of Intangibles, Supplemental

-

0.1

0.1

0.2

0.1

Research & Development Exp, Supplemental

4.8

1.7

0.5

0.4

0.6

Advertising Expense, Supplemental

0.2

0.4

0.1

0.1

0.0

    Current Tax

1.7

2.2

2.2

2.6

2.9

Current Tax - Total

1.7

2.2

2.2

2.6

2.9

    Deferred Tax

-0.2

-0.1

-0.2

0.0

0.0

Deferred Tax - Total

-0.2

-0.1

-0.2

0.0

0.0

Income Tax - Total

1.5

2.2

2.0

2.6

2.8

 



 

Annual Balance Sheet

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate

6.2357

6.294

6.5897

6.827

6.823

Auditor

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash and Cash Equivalent

41.1

58.4

132.2

14.5

10.5

    Financial Assets - Trading

-

-

-

0.0

0.0

    Notes Receivable

4.1

4.9

2.1

1.4

0.3

    Accounts receivable, net

39.1

-

-

-

11.7

    Accounts Receivable, Gross

-

31.4

16.8

11.8

-

    Provision for Doubtful Accounts

-

-2.3

-1.5

-0.6

-

    Payment in Advance

9.0

10.8

6.1

2.4

1.2

    Interest Receivable

-

-

0.0

-

-

    Other Receivables

1.9

1.4

0.3

1.2

0.5

    Inventory, Net

43.8

-

-

-

-

    Raw Material

-

8.1

7.1

3.3

2.6

    Semi-finished Products

-

7.9

8.0

2.9

3.7

    Finished Products

-

3.2

1.8

1.5

1.0

    Provision/Allowance for Inventory

-

-

-

0.0

-

Total Current Assets

139.0

123.8

172.9

38.4

31.5

 

 

 

 

 

 

    Investment properties

0.7

0.8

0.8

-

-

    Construction Materials

4.6

-

-

-

-

    Fixed assets

188.3

-

-

-

29.1

    Buildings and Structures

-

22.7

24.0

25.2

-

    Machinary Equipment

-

66.1

59.3

38.1

-

    Electronic Equipment

-

0.4

1.4

0.2

-

    Analyzaion Equipment

-

0.7

0.7

0.7

-

    Transportation Equipment

-

2.2

1.7

1.2

-

    Office Equipments

-

0.0

0.0

-

-

    Accumulated Depreciation

-

-22.4

-25.8

-21.6

-

    Provision for Impairment of Fixed Assets

-

-

-0.5

-

-

    Construction in Progress

29.7

77.8

13.2

6.4

1.2

    Intangible Assets, Net

7.9

5.2

2.9

6.9

5.5

    Development expenses

3.0

0.5

-

-

-

    Deferred Tax Assets

0.8

0.6

0.5

0.3

0.4

Total Assets

373.9

278.3

251.1

95.9

67.6

 

 

 

 

 

 

    Short Term Borrowing

78.7

40.5

27.5

18.7

18.8

    Notes Payable

47.4

4.8

13.1

2.3

3.2

    Accounts Payable

41.7

18.6

9.9

10.3

7.1

    Customer Advance

4.1

4.0

3.8

4.9

4.1

    Accrued Payroll

0.6

0.7

0.8

0.8

0.7

    Tax Payable

-9.5

-3.4

-1.1

-0.6

-0.3

    Interest Payable

0.2

0.1

0.1

0.1

0.0

    Dividend Payable

-

-

0.0

3.2

0.0

    Other Creditors

2.4

2.4

2.5

2.5

2.4

    Current Portion of LT Debt

16.4

14.3

5.4

3.7

1.5

    Other Current Liabilities

0.0

1.4

1.5

0.1

0.2

Total Current Liabilities

182.0

83.4

63.6

46.0

37.7

 

 

 

 

 

 

    Long Term Borrowing

-

13.0

23.3

14.3

3.3

Total Long Term Debt

-

13.0

23.3

14.3

3.3

 

 

 

 

 

 

    Other Non-current Liabilities

2.4

0.8

0.8

0.0

0.1

Total Liabilities

184.4

97.3

87.6

60.3

41.1

 

 

 

 

 

 

    Capital Stock

34.2

21.2

11.2

8.1

8.1

    Paid in Capital

97.8

108.0

112.1

0.5

0.5

    Surplus Reserve

7.0

6.0

4.4

3.1

1.7

    Undistributed Profit

48.5

43.8

33.8

22.5

15.1

    Special Reserve

2.1

2.2

2.0

1.4

1.2

Total Equity

189.5

181.1

163.5

35.6

26.5

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

373.9

278.3

251.1

95.9

67.6

 

 

 

 

 

 

    S/O-A Share

213.1

213.1

213.1

158.4

158.4

Total Common Shares Outstanding

213.1

213.1

213.1

158.4

158.4

T/S-A Share

0.0

0.0

0.0

0.0

0.0

Customer Advance

4.1

4.0

3.8

4.9

4.1

Accumulated Intangible Amort, Suppl.

-

0.6

0.4

0.5

-

Full-Time Employees

-

1,535

1,395

1,340

1,313

Number of Common Shareholders

-

12,911

12,317

-

-

 

 

 

Annual Cash Flows

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Updated Normal
31-Dec-2010

Updated Normal
30-Jun-2010

Updated Normal
30-Jun-2010

Filed Currency

CNY

CNY

CNY

CNY

CNY

Exchange Rate (Period Average)

6.310555

6.46438

6.768989

6.831007

6.950445

Auditor

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Jiangsu Gongzheng Tianye CPA

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash from Sale of Goods & Services

206.6

175.3

140.9

101.2

145.7

    Cash Paid for Goods and Services

-167.4

-162.7

-122.1

-76.8

-121.3

    Amortization of Intangibles

0.2

0.1

0.1

0.2

0.1

    Refund of Taxes

5.8

5.7

4.6

0.4

0.5

    Cash Paid to/for Employees

-15.9

-

-

-

-

    Other Cash from Operating Activities

0.3

2.0

0.3

3.6

2.2

    All Taxes Paid

-1.9

-3.2

-2.7

-3.5

-6.5

    Other Cash Paid for Operating Activities

-18.1

-14.2

-10.6

-6.2

-6.8

Cash from Operating Activities

9.3

3.0

10.4

18.7

13.9

 

 

 

 

 

 

    Sale/Maturity/Redemption of Investments

-

-

-

0.0

0.0

    Cash from Return on Investments

-

-

-

0.0

0.0

    Sale of FA/Intangibles/Other Assets

0.0

0.3

0.1

0.0

0.0

    Other Cash from Investing Activities

2.4

1.5

8.1

-

-

    Net cash paid for acquisition of subsidi

-

-

-0.3

-

-

    Capital Expenditure

-68.1

-79.7

-31.3

-23.2

-8.8

Cash from Investing Activities

-65.7

-77.8

-23.4

-23.1

-8.8

 

 

 

 

 

 

    Cash from Investors

-

-

112.7

0.0

0.0

    Cash from Borrowings

84.1

42.5

41.9

33.3

21.1

    Repayment of Borrowings

-57.8

-33.8

-24.2

-20.2

-19.8

    Cash Paid for Dividend and Interest

-8.9

-7.3

-6.0

-4.0

-1.9

    Cash paid for other financing activities

-

-

-1.1

-

-

Cash from Financing Activities

17.5

1.4

123.3

9.2

-0.6

 

 

 

 

 

 

Foreign Exchange Effects

-0.6

-1.0

-0.3

0.0

0.0

Net Change in Cash

-39.5

-74.4

110.0

4.8

4.6

 

 

 

 

 

 

    Depreciation

11.5

7.5

5.2

3.5

3.3

Net Cash - Beginning Balance

55.8

128.9

13.1

8.3

3.5

Net Cash - Ending Balance

16.3

54.5

123.1

13.0

8.1

 

 

Financial Health

 

Financials in: USD (mil)

 

Except for share items (millions) and per share items (actual units)

 

 

 

Key Indicators USD (mil)

 

Quarter
Ending
31-Mar-2013

Quarter
Ending
Yr Ago

Annual
Year End
31-Dec-2012

1 Year
Growth

3 Year
Growth

5 Year
Growth

Total Revenue1 (?)

0.1

-99.89%

201.0

10.96%

26.44%

18.17%

Research & Development1 (?)

-

-

4.8

-

-

-

Operating Income1 (?)

-

-

11.0

-29.88%

-9.35%

10.27%

Income Available to Common Excl Extraord Items1 (?)

-

-

9.4

-29.04%

-15.71%

14.50%

Basic EPS Excl Extraord Items1 (?)

-

-

0.04

-28.50%

-23.46%

8.06%

Capital Expenditures2 (?)

0.0

-99.91%

68.1

-16.55%

39.54%

46.22%

Cash from Operating Activities2 (?)

0.0

-99.64%

9.3

200.85%

-22.81%

-2.91%

Free Cash Flow (?)

0.0

-

-59.5

-

-

-

Total Assets3 (?)

-

-

373.9

33.10%

52.72%

43.65%

Total Liabilities3 (?)

-

-

184.4

87.87%

40.84%

30.60%

Total Long Term Debt3 (?)

-

-

0.0

-

-

-

Total Common Shares Outstanding3 (?)

-

-

213.1

0.00%

10.40%

6.11%

1-ExchangeRate: CNY to USD Average for Period

6.226074

 

6.310555

 

 

 

2-ExchangeRate: CNY to USD Average for Period

6.226074

 

6.310555

 

 

 

3-ExchangeRate: CNY to USD Period End Date

 

 

6.235700

 

 

 

Key Ratios

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Profitability

Gross Margin (?)

19.34%

21.35%

22.13%

25.97%

21.08%

Operating Margin (?)

5.47%

8.65%

9.75%

14.84%

11.43%

Pretax Margin (?)

5.41%

8.54%

9.92%

18.60%

12.94%

Net Profit Margin (?)

4.67%

7.30%

8.40%

15.76%

10.77%

Financial Strength

Current Ratio (?)

0.76

1.48

2.72

0.83

0.83

Long Term Debt/Equity (?)

0.00

0.07

0.14

0.40

0.13

Total Debt/Equity (?)

0.75

0.40

0.42

1.10

1.01

Interest Coverage (?)

20.99

-

-

-

-

Management Effectiveness

Return on Assets (?)

2.90%

4.90%

6.65%

17.72%

23.22%

Return on Equity (?)

5.10%

7.53%

11.63%

46.68%

75.47%

Efficiency

Receivables Turnover (?)

5.04

6.74

8.66

6.99

11.26

Inventory Turnover (?)

5.12

7.73

8.67

9.08

13.78

Asset Turnover (?)

0.62

0.67

0.79

1.12

2.16

Market Valuation USD (mil)

P/E (TTM) (?)

32.46

.

Enterprise Value2 (?)

412.4

Price/Sales (TTM) (?)

1.53

.

Enterprise Value/Revenue (TTM) (?)

2.03

Price/Book (MRQ) (?)

1.64

.

Enterprise Value/EBITDA (TTM) (?)

22.64

Market Cap as of 21-Jun-20131 (?)

316.3

.

 

 

1-ExchangeRate: CNY to USD on 21-Jun-2013

6.131110

 

 

 

2-ExchangeRate: CNY to USD on 31-Dec-2012

6.235700

 

 

 

 

 

Annual Ratios

 

Financials in: USD (mil)

 

Except for share items (millions) and per share items (actual units)

 

 

 

 



 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Financial Strength

Current Ratio (?)

0.76

1.48

2.72

0.83

0.83

Quick/Acid Test Ratio (?)

0.47

1.12

2.36

0.61

0.61

Working Capital1 (?)

-43.0

40.3

109.3

-7.6

-6.2

Long Term Debt/Equity (?)

0.00

0.07

0.14

0.40

0.13

Total Debt/Equity (?)

0.75

0.40

0.42

1.10

1.01

Long Term Debt/Total Capital (?)

0.00

0.05

0.10

0.19

0.06

Total Debt/Total Capital (?)

0.43

0.29

0.30

0.52

0.50

Interest Coverage (?)

20.99

-

-

-

-

Payout Ratio (?)

0.00%

58.53%

0.00%

0.00%

0.00%

Effective Tax Rate (?)

13.69%

14.47%

15.30%

15.27%

16.77%

Total Capital1 (?)

331.9

253.6

232.9

74.6

53.2

 

 

 

 

 

 

Efficiency

Asset Turnover (?)

0.62

0.67

0.79

1.12

2.16

Inventory Turnover (?)

5.12

7.73

8.67

9.08

13.78

Days In Inventory (?)

71.34

47.21

42.09

40.22

26.48

Receivables Turnover (?)

5.04

6.74

8.66

6.99

11.26

Days Receivables Outstanding (?)

72.49

54.17

42.14

52.21

32.42

Revenue/Employee2 (?)

-

118,335

99,439

68,598

101,364

Operating Income/Employee2 (?)

-

10,241

9,691

10,182

11,587

EBITDA/Employee2 (?)

-

15,306

13,598

12,935

14,233

 

 

 

 

 

 

Profitability

Gross Margin (?)

19.34%

21.35%

22.13%

25.97%

21.08%

Operating Margin (?)

5.47%

8.65%

9.75%

14.84%

11.43%

EBITDA Margin (?)

6.30%

12.93%

13.68%

18.86%

14.04%

EBIT Margin (?)

5.74%

8.65%

9.75%

14.84%

11.43%

Pretax Margin (?)

5.41%

8.54%

9.92%

18.60%

12.94%

Net Profit Margin (?)

4.67%

7.30%

8.40%

15.76%

10.77%

R&D Expense/Revenue (?)

2.38%

-

-

-

-

COGS/Revenue (?)

79.57%

78.65%

77.87%

74.03%

78.92%

SG&A Expense/Revenue (?)

9.06%

10.51%

10.64%

9.73%

7.57%

 

 

 

 

 

 

Management Effectiveness

Return on Assets (?)

2.90%

4.90%

6.65%

17.72%

23.22%

Return on Equity (?)

5.10%

7.53%

11.63%

46.68%

75.47%

 

 

 

 

 

 

Valuation

Free Cash Flow/Share2 (?)

-0.28

-0.37

-0.10

-0.03

0.03

Operating Cash Flow/Share 2 (?)

0.04

0.01

0.05

0.12

0.09

1-ExchangeRate: CNY to USD Period End Date

6.2357

6.294

6.5897

6.827

6.823

2-ExchangeRate: CNY to USD Average for Period

6.2357

6.294

6.5897

6.827

6.823

 

Current Market Multiples

Market Cap/Earnings (TTM) (?)

32.46

Market Cap/Equity (MRQ) (?)

1.64

Market Cap/Revenue (TTM) (?)

1.53

Market Cap/EBIT (TTM) (?)

17.64

Market Cap/EBITDA (TTM) (?)

17.64

Enterprise Value/Earnings (TTM) (?)

43.04

Enterprise Value/Equity (MRQ) (?)

2.18

Enterprise Value/Revenue (TTM) (?)

2.03

Enterprise Value/EBIT (TTM) (?)

23.39

Enterprise Value/EBITDA (TTM) (?)

23.39

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.34

UK Pound

1

Rs.90.78

Euro

1

Rs.77.81

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.